Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 4-9

  Zeng, Lili ^a,b   Wang, Yongting ^b   Liu, Jianrong ^a   Wang, Ling ^a   Weng, Suiqing ^a   Chen, Kewei ^b   Domino, Edward F ^c   Yang, Guo Yuan ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Neuroscience and Neuroengineering Research Center Med X Research Institute and School of Biomedical Engineering   (China)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cytokine; Inflammation; Interleukin 6; Leukocyte; Stroke

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; NETWORK LEARNING; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; STROKE PATIENT; UPREGULATION;

CYTOKINE; INFLAMMATION; INTERLEUKIN 6; LEUKOCYTE; STROKE;

AGED; BRAIN ISCHEMIA; CHINA; COMORBIDITY; CYTOKINES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84880136275     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.04.037     Document Type: Note

References (22)

1. Becker K. Modulation of the postischemic immune response to improve stroke outcome. Stroke 2010, 41:S75.
2. Brea D., Sobrino T., Ramos-Cabrer P., Castillo J. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovasc. Dis. 2009, 27:48-64.
3. Davi G., Tuttolomondo A., Santilli F., Basili S., Ferrante E., Raimondo D., Pinto A., Licata G. CD40 ligand MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. J. Atheroscler. Thromb. 2009, 16:703-713.
4. Emsley H.C., Smith C.J., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., Illingworth K., Scarth S., Wickramasinghe V., Hoadley M.E., Rothwell N.J., Tyrrell P.J., Hopkins S.J. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol. 2007, 7:5.
5. Ferrarese C., Mascarucci P., Zoia C., Cavarretta R., Frigo M., Begni B., Sarinella F., Frattola L., De Simoni M. Increased cytokine release from peripheral blood cells after acute stroke. J. Cereb. Blood Flow Metab. 1999, 19:1004-1009.
6. Foca A., Berlinghieri M.C., Barreca G.S., Placanica P.M., Diana R., Liberto M.C., Matera G. Kinetics of IL-8, MIP-1 alpha, TNF alpha, IL-1 beta, IL-1ra and IL-10 in human whole blood samples triggered by smooth and rough LPS. New Microbiol. 1998, 21:123-130.
7. Jin R., Yang G., Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779.
8. Kostulas N., Kivisakk P., Huang Y., Matusevicius D., Kostulas V., Link H. Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 1998, 29:462-466.
9. Kostulas N., Pelidou S.H., Kivisakk P., Kostulas V., Link H. Increased IL-1beta IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 1999, 30:2174-2179.
10. Lakhan S., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 2009, 7:97.
11. Liesz A., Hagmann S., Zschoche C., Adamek J., Zhou W., Sun L., Hug A., Zorn M., Dalpke A., Nawroth P. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 2009, 40:2849.
12. Rajapakse J.C., Zhou J. Learning effective brain connectivity with dynamic Bayesian networks. Neuroimage 2007, 37:749-760.
13. Schmidt M., Niculescu-Mizil A., Murphy K. Learning Graphical Model Structure Using L1-Regularization Paths 1999/2007, vol. 22:1278. AAAI Press/MIT Press, Menlo Park, CA/Cambridge, MA/London.
14. Schwarz G. Estimating the dimension of a model. Ann. Stat. 1978, 6:461-464.
15. Shalaby M.R., Waage A., Aarden L., Espevik T. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 1989, 53:488-498.
16. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D. Pivotal role of cerebral interleukin-17 producing T cells in the delayed phase of ischemic brain injury. Nat. Med. 2009, 15:946-950.
17. Smith C., Emsley H., Gavin C., Georgiou R., Vail A., Barberan E., Del Zoppo G., Hallenbeck J., Rothwell N., Hopkins S. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome,. BMC Neurol. 2004, 4:2.
18. Tuttolomondo A., Di Raimondo D., di Sciacca R., Pinto A., Licata G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008, 14:3574-3589.
19. Tuttolomondo A., Di Sciacca R., Di Raimondo D., Serio A., D'Aguanno G., La Placa S., Pecoraro R., Arnao V., Marino L., Monaco S. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J. Neuroimmunol. 2009, 215:84-89.
20. Wang Q., Tang X., Yenari M. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53.
21. Whiteley W., Jackson C., Lewis S., Lowe G., Rumley A., Sandercock P., Wardlaw J., Dennis M., Sudlow C. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009, 6:e100045.
22. Zhu Y., Saito K., Murakami Y., Asano M., Iwakura Y., Seishima M. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia. Neurosci. Lett. 2006, 393:122-126.